Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system - PubMed (original) (raw)

. 1997 Feb;280(2):551-60.

Affiliations

PMID: 9023263

Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system

Y Deguchi et al. J Pharmacol Exp Ther. 1997 Feb.

Abstract

This study was performed to evaluate quantitatively the brain distribution and the efflux transport across the blood-brain barrier of probenecid, using in vivo microdialysis and in situ brain perfusion techniques. The brain interstitial fluid (ISF)-to-plasma cerebrospinal fluid (CSF)-to-plasma and brain tissue-to-plasma unbound concentration ratios of probenecid at steady state were less than unity, which suggests restricted distribution in the brain. An uphill concentration gradient from ISF to plasma and a downhill concentration gradient from CSF to ISF were observed. Kinetic analysis revealed that the efflux clearance from brain ISF to plasma (0.0373 ml/min/g brain) was significantly greater than the influx clearance from plasma to brain (0.00733 ml/min/g brain). The ratio of the ISF concentration (Cisf) to the plasma unbound concentration (Cp,f) of probenecid was increased 2- to 3-fold by salicylate (3.7 mM) and benzoate (3.6 mM), which are accepted as substrates of the monocarboxylic acid transport system, compared with the same ratio for the control. In addition, the ratio Cisf/Cp,f was increased by treatment with N-ethylmaleimide, a sulfhydryl-modifying agent, whereas p-aminohippuric acid and choline did not produce increasing effects on Cisf/Cp,f. These data suggest that the restricted distribution of probenecid in the brain may be ascribed to efficient efflux from the brain ISF, which may be regulated by the monocarboxylic acid transport system at a relatively high ISF concentration.

PubMed Disclaimer

Cited by

Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs).
Huttunen J, Adla SK, Markowicz-Piasecka M, Huttunen KM. Huttunen J, et al. Pharmaceutics. 2022 Jun 10;14(6):1234. doi: 10.3390/pharmaceutics14061234. Pharmaceutics. 2022. PMID: 35745806 Free PMC article. Review.
Current Chemical, Biological, and Physiological Views in the Development of Successful Brain-Targeted Pharmaceutics.
Markowicz-Piasecka M, Markiewicz A, Darłak P, Sikora J, Adla SK, Bagina S, Huttunen KM. Markowicz-Piasecka M, et al. Neurotherapeutics. 2022 Apr;19(3):942-976. doi: 10.1007/s13311-022-01228-5. Epub 2022 Apr 7. Neurotherapeutics. 2022. PMID: 35391662 Free PMC article. Review.
Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems.
Neumaier F, Zlatopolskiy BD, Neumaier B. Neumaier F, et al. Pharmaceutics. 2021 Sep 23;13(10):1542. doi: 10.3390/pharmaceutics13101542. Pharmaceutics. 2021. PMID: 34683835 Free PMC article. Review.
Inhibition of blood-brain barrier efflux transporters promotes seizure in pregnant rats: Role of circulating factors.
Johnson AC, Hammer ES, Sakkaki S, Tremble SM, Holmes GL, Cipolla MJ. Johnson AC, et al. Brain Behav Immun. 2018 Jan;67:13-23. doi: 10.1016/j.bbi.2017.07.017. Epub 2017 Jul 21. Brain Behav Immun. 2018. PMID: 28739514 Free PMC article.
Effect of Efflux Transporter Inhibition on the Distribution of Fluconazole in the Rat Brain.
Wang W, Zheng N, Zhang J, Huang X, Yu S. Wang W, et al. Neurochem Res. 2017 Aug;42(8):2274-2281. doi: 10.1007/s11064-017-2240-x. Epub 2017 Mar 24. Neurochem Res. 2017. PMID: 28337665

Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system - PubMed (original) (raw)